Genomics and Epigenomics Shared Resource


Identification of miRNA-mRNA associations in hepatocellular carcinoma using hierarchical integrative model. Varghese RS, Zhou Y, Barefoot M, Chen Y, Di Poto C, Balla AK, Oliver E, Sherif ZA, Kumar D, Kroemer AH, Tadesse MG, Ressom HW. (2020). BMC Med Genomics. 2020 Mar 30;13(1):56. doi: 10.1186/s12920-020-0706-1. PMID: 32228601

Depletion of the Transcriptional Coactivator Amplified in Breast Cancer 1 (AIB1) Uncovers Functionally Distinct Subpopulations in Triple-Negative Breast Cancer. Saenz FR, Ory V, Schmidt MO, Kallakury BV, Mueller SC, Furth PA, Wellstein A, Riegel AT. Neoplasia. 2019 Oct; 21(10): 963–973. Published online 2019 Aug 19. doi: 10.1016/j.neo.2019.07.001 PMID: 31437536 PMCID: PMC6706655

Expanding primary cells from mucoepidermoid and other salivary gland neoplasms for genetic and chemosensitivity testing. Alamri AM, Liu X, Blancato JK, Haddad BR, Wang W, Zhong X, Choudhary S, Krawczyk E, Kallakury BV, Davidson BJ, Furth PA. Dis Model Mech. 2018 Jan 1; 11(1): dmm031716. doi: 10.1242/dmm.031716 PMID: 29419396 PMCID: PMC5818080

Integrated Molecular Analysis of Tamoxifen-Resistant Invasive Lobular Breast Cancer Cells Identifies MAPK and GRM/mGluR Signaling as Therapeutic Vulnerabilities. Stires H, Heckler MM, Fu X, Li Z, Grasso CS, Quist MJ, Lewis JA, Klimach U, Zwart A, Mahajan A, Győrffy B, Cavalli LR, Riggins RB. Mol Cell Endocrinol. 2018 Aug 15; 471: 105–117. Published online 2017 Sep 19. doi: 10.1016/j.mce.2017.09.024 PMID: 28935545 PMCID: PMC5858970

A Mechanism of Resistance to Antibody-Targeted Immune Attack. Aldeghaither DS, Zahavi DJ, Murray JC, Fertig EJ, Graham GT, Zhang YW, O’Connell A, Ma J, Jablonski SA, Weiner LM. Cancer Immunol Res. 2019 Feb; 7(2): 230–243. Published online 2018 Dec 18. doi: 10.1158/2326-6066.CIR-18-0266 PMID: 30563830